Investors are likely concerned about Pediatrix's (MD) lower enrollment in commercial insurance programs, escalating practice salaries and benefits and net borrowings.
Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia...
Pediatrix Medical Group, Inc. (NYSE: MD) today announced that it will present on Tuesday, May 9, 2023 at 5:00 pm PT to investors attending the 2023 Bank of America Health Care Conference in Las Vegas,...
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of 4.55% and 0.75%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.17 per...
Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 2, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2023....
Pediatrix Medical Group (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pediatrix Medical Group, Inc. (NYSE: MD) today announced that its board of directors has elected James D. Swift, M.D., the Company’s chief executive officer, as a director effective March 8, 2023. This...
Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, babies and children, will host the top meeting in neonatal medicine Feb. 22-24 in...
Pediatrix (MD) anticipates 2023 adjusted EBITDA to be within $235-$245 million.